Vascular Solutions Price Target Increased to $22.50 by Analysts at Canaccord Genuity (VASC)
Equities research analysts at Canaccord Genuity lifted their price objective on shares of Vascular Solutions (NASDAQ:VASC) from $21.00 to $22.50 in a research note issued to investors on Wednesday, American Banking News reports. The firm currently has a “buy” rating on the stock. Canaccord Genuity’s price objective would indicate a potential upside of 14.97% from the company’s current price.
Vascular Solutions (NASDAQ:VASC) traded up 4.71% during mid-day trading on Wednesday, hitting $19.57. The stock had a trading volume of 125,671 shares. Vascular Solutions has a 1-year low of $12.98 and a 1-year high of $17.37. The stock’s 50-day moving average is $16.30 and its 200-day moving average is $15.75. The company has a market cap of $328.6 million and a P/E ratio of 29.71.
Vascular Solutions (NASDAQ:VASC) last released its earnings data on Tuesday, October 22nd. The company reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.12. The company had revenue of $28.01 million for the quarter, compared to the consensus estimate of $27.10 million. During the same quarter in the previous year, the company posted $0.16 earnings per share. The company’s revenue for the quarter was up 14.1% on a year-over-year basis. Analysts expect that Vascular Solutions will post $0.68 EPS for the current fiscal year.
Separately, analysts at Feltl & Co. raised their price target on shares of Vascular Solutions from $18.75 to $21.00 in a research note to investors on Wednesday. They now have a “buy” rating on the stock. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $19.83.
Vascular Solutions, Inc (NASDAQ:VASC) is a medical device company focused on providing clinically advanced solutions to interventional cardiologists and interventional radiologists.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.